Valneva SE (VALN) Net Equity Issued and Repurchased (2021 - 2023)

Valneva SE (VALN) posted quarterly Net Equity Issued and Repurchased of $51207.9 for Q3 2023, up 114.52% year-on-year from $23871.4 in Q3 2022, and up 149.45% on a QoQ basis from -$103553.8 in Q2 2023.

Valneva SE (VALN) Net Equity Issued and Repurchased (2021 - 2023) Analysis & Trends

Valneva SE (VALN) has reported Net Equity Issued and Repurchased for 3 consecutive years, with $51207.9 the latest figure, recorded in Q3 2023.

  • Quarterly Net Equity Issued and Repurchased rose 114.52% year-over-year to $51207.9 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $108.8 million (down 45.54% YoY) and the FY2022 annual result came in at $216.0 million, up 13.94% from the prior year.
  • Net Equity Issued and Repurchased rose to $51207.9 in Q3 2023 per VALN's latest filing, from -$103553.8 in the prior quarter.
  • Over the last five years, Net Equity Issued and Repurchased for VALN reached as high as $109.1 million in Q4 2022 and fell as low as -$352765.8 in Q3 2022.
  • A 3-year average of $36.9 million and a median of $2.5 million in 2021 frame the typical range for Net Equity Issued and Repurchased.
  • Annual changes were most pronounced in 2022 — Net Equity Issued and Repurchased tumbled 167.24% — and 2023, when it surged 114.52%.
  • Year by year, Net Equity Issued and Repurchased stood at $92.8 million in 2021, then rose by 17.52% to $109.1 million in 2022, then slumped by 99.95% to $51207.9 in 2023.
  • According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $51207.9, -$103553.8, and -$220763.1 for Q3 2023, Q2 2023, and Q1 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 163.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 141.90 Mn
10 Valneva SE 803.90 Mn 680.66 Mn 5.38 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2023 51,207.94
Sep 30, 2023 51,207.94
Jun 30, 2023 -103,553.84
Jun 30, 2023 -103,553.84
Mar 31, 2023 -220,763.13
Mar 31, 2023 -220,763.13
Dec 31, 2022 109.06 Mn
Dec 31, 2022 109.06 Mn
Sep 30, 2022 -352,765.82
Sep 30, 2022 -352,765.82
Jun 30, 2022 103.08 Mn
Jun 30, 2022 103.08 Mn
Mar 31, 2022 4.24 Mn
Mar 31, 2022 4.24 Mn
Dec 31, 2021 92.80 Mn
Dec 31, 2021 92.80 Mn
Sep 30, 2021 -132,002.70
Sep 30, 2021 -132,002.70
Jun 30, 2021 94.41 Mn
Jun 30, 2021 94.41 Mn